Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026

Date: September 29th, 2026 Department of Corporate Service (DCS-CRD), BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400001 Sub: Proceedings of the 35th Annual General Meeting of Norris Medicines Limited held for the financial year 2025-2026 on September 29th, 2026. Ref.: Norris Medicines Limited, Scrip Code- 524414 Dear Sir/Madam, Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the proceedings of the 35th Annual General Meeting (AGM) of Norris Medicines Limited, the Company, held today i.e. Tuesday, 29th September, 2026 through Video Conferencing/Other Audio-Visual Means. The Meeting commenced at 02:30 p.m. (IST) and concluded at 02:45 p.m. (IST). The detailed result of the matters that were put to vote, as required under Regulation 44(3) of the Listing Regulations shall be submitted separately. Kindly take the above on record and acknowledge receipt of the same. Thank You, Yours Faithfully, FOR NORRIS MEDICINES LIMITED VIMAL D. SHAH MANAGING DIRECTOR DIN: 01506655 35th ANNUAL GENERAL MEETING Through Video Conferencing (VC) or Other Audio Visual Means (OAVM) Date – 29th September, 2026 Time – 02.30 P.M PROCEEDINGS OF THE 35th ANNUAL GENERAL MEETING OF NORRIS MEDICINES LIMITED HELD ON TUESDAY, 29TH SEPTEMBER, 2026 AT 02.30 P.M. THROUGH VIDEO CONFERENCING (VC) OR OTHER AUDIO- VISUAL MEANS (OAVM) As per the Notice dated 03rd September,2026, the 35th (Thirty-fifth) Annual General Meeting (AGM) of the Company was held on Tuesday, 29th September, 2026 at 2.30 P.M. through Video Conferencing or other audio video visual means. Mr. Vimal Dhirendra Shah - Chairman elected by the Directors of the Company at the AGM, presided over the proceeding of this 35th Annual General Meeting of the Company. Mr. Iqubal being the Chief Financial Officer (CFO) of the Company gave a warm welcome to all the members and dignitaries. There being 40 Members being present in the meeting the CFO declared the meeting as validly convened as per terms of section 103 of Companies Act, 2013 an as per Articles of Association of Company. Thereafter, he introduced the following Board Members and Management on the panel;  Mr. Vimal D. Shah  Mr. Angamuthu Vadivel  Mr. Praveenchand Bafna The CFO acknowledged the attendance of Secretarial Auditor and Scrutinizer to the 35th Annual General Meeting, Mr. Hemant Shetye, Company Secretary. He then invited Mr. Chairman to proceed with his speech. Mr. Vimal D. Shah, Chairman then addressed the members and gave an overview of the financial performance of the Company for the financial year ended 31st March, 2026 and its future outlook and opportunity with challenges in Pharmaceutical Industries. The Chief Financial Officer (CFO) then informed about formal procedure for attending AGM and relevant cut-off dates and E-voting schedule, he informed that due to virtual AGM, physical attendance of the members was not required and therefore appointing a proxy is not applicable. The CFO further informed that register and relevant document are available for inspection in e-mode and also appealed for E-voting which was kept open from Saturday, 26th September, 2026 at 9:00 A.M. till Monday, 28th September, 2026, 05:00 P.M. The voting rights of the shareholders are in proportion to the shares held by them as on the cut-off date that is Tuesday, 22nd September, 2026. The Company has availed the services of Purva Sharegistry India Private Limited for both remote e-voting and AGM e-voting. It was informed to the Members that the Notice of the meeting and addendum to the notice was already sent to the members and therefore was taken as read. Permission of the Members to take the Auditor's Report as read was sought. The following Agenda Items as set out in the notice of convening the 35th Annual General Meeting were transacted by remote e-voting and voting at the AGM. Ordinary Business: 1. Ordinary Resolution - To receive, consider and adopt the Audited Financial Statements of the Company for the year ended 31st March, 2026 together with Reports of Board of Directors and Auditors thereon. 2. Ordinary Resolution - To appoint a Director in place of Mr. Praveen J. Bafna, (DIN No. 06538685), who retires by rotation and being eligible, offers himself for re-appointment. Special Business: 3. Special Resolution - Appointment of Mr. Vimal D. Shah (Din: 01506655) As A Managing Director of the Company. 4. Special Resolution- Increase in the limits of borrowing authorized by the company. 5. Special Resolution- Authorization for sale, lease, or disposal of the whole or substantially the whole of the company's undertaking by the Company. 6. Special Resolution - Enhancement of the existing limit under Section 186 of the Companies Act, 2013. The CFO, Mr. Iqubal Patel informed the members that the result of remote e- voting and in AGM e-voting along with the consolidated scrutinizers report shall be announced within 2 working days from the conclusion of AGM and would be displayed on the website of the Company. He also informed that result would also be intimated to the BSE Ltd. The CFO then invited members present who have registered themselves in advance by sending requests from their registered e-mail ID to express their views /ask question in the AGM. Thereafter the Chairman addressed to the queries raised by members. Mr. Angamuthu Vadivel thanked all the members for their presence and support and then 35th AGM was concluded with vote of thanks to chair. Meeting Commenced at 02.30 P.M. Meeting Concluded at 02:45 P.M. FOR NORRIS MEDICINES LIMITED VIMAL D. SHAH MANAGING DIRECTOR DIN: 01506655 Date: 29th September, 2026